Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin S Im

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplantTaha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2011
Structural reorganization of the antigen-binding groove of human CD1b for presentation of mycobacterial sulfoglycolipidsLuis F Garcia-Alles, Anthony Collmann, Cees Versluis, et al.
Immunity|June 23, 2009
Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activationJin S Im, Pooja Arora, Gabriel Bricard, et al.
Frontiers in Immunology|June 26, 2026
Human NKT10 cells are enriched in cord-derived invariant natural killer T cells and mediate immune-regulation in a xenogeneic graft-versus-host disease modelAbel Trujillo-Ocampo, Pamella Borges, Maison Grefe, et al.
American Journal of Hematology|February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trialIssa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Frontiers in Immunology|November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignanciesHarjeet Singh, Samer A Srour, Denái R Milton, et al.
Frontiers in Immunology|February 8, 2021
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary ComplicationsSang T Kim, Ajay Sheshadri, Vickie Shannon, et al.
Blood Advances|January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvementSerkan Akin, Chitra Hosing, Issa Khouri, et al.
Transplantation and Cellular Therapy|May 5, 2022
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideRohtesh S Mehta, Rima M Saliba, Sassine Ghanem, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplantTaha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2011
Structural reorganization of the antigen-binding groove of human CD1b for presentation of mycobacterial sulfoglycolipidsLuis F Garcia-Alles, Anthony Collmann, Cees Versluis, et al.
Immunity|June 23, 2009
Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activationJin S Im, Pooja Arora, Gabriel Bricard, et al.
Frontiers in Immunology|June 26, 2026
Human NKT10 cells are enriched in cord-derived invariant natural killer T cells and mediate immune-regulation in a xenogeneic graft-versus-host disease modelAbel Trujillo-Ocampo, Pamella Borges, Maison Grefe, et al.
American Journal of Hematology|February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trialIssa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Frontiers in Immunology|November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignanciesHarjeet Singh, Samer A Srour, Denái R Milton, et al.
Frontiers in Immunology|February 8, 2021
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary ComplicationsSang T Kim, Ajay Sheshadri, Vickie Shannon, et al.
Blood Advances|January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvementSerkan Akin, Chitra Hosing, Issa Khouri, et al.
Transplantation and Cellular Therapy|May 5, 2022
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideRohtesh S Mehta, Rima M Saliba, Sassine Ghanem, et al.
Pageof 5